Reller MD, Morris CD. Is Down's syndrome a risk factor for poor outcome after repair of congenital heart defects? J Pediatr 1998; 132: 738–741.
Van Mierop LHS. Diagnostic code for congenital heart disease. Pediatr Cardiol 1984; 5: 331–362.
Van Mierop LHS. Diagnostic code for congenital heart disease, supplement. Pediatr Cardiol 1986; 7: 31–34.
Pradat P. Noncardiac malformations at major congenital heart defects. Pediatr Cardiol 1997; 18: 11–18.
Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin Perinatol 2001; 28: 1–9.
Tennstedt C, Chaui R, Korner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 1999; 82: 34–39.
Lurie IW, Kappetein AP, Loffredo CA, Ferencz C. Non-cardiac malformations in individuals with outflow tract defects of the heart: the Baltimore-Washington Infant Study (1981–1989). Am J Med Genet 1995; 59: 76–89.
Harris JA, Francannet C, Pradat P, Robert E. The epidemiology of cardiovascular defects, Part 2: A study based on data from three large registries of congenital malformations. Pediatr Cardiol 2003; 24: 222–235.
Grech V, Gatt M. Syndromes and malformations associated with congenital heart disease in a population-based study. Int J Cardiol 1999; 28: 151–156.
Gaynor JW, Mahle WT, Cohen MI, et al. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg 2002; 22: 82–89.
Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994; 71: 3–7.
Sharland GK, Lockhart SM, Chita SK, Allan LD. Factors influencing the outcome of congenital heart disease detected prenatally. Arch Dis Child 1991; 66: 284–287.
Garne E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultasound Obstet Gynecol 2001; 17: 386–391.
Eskild A, Nesheim B, Berglund T, Totlandsdal JK, Andresen JF. Induced abortion attributed to fetal maldevelopment in Norway in 1996 and 1997. Tidsskr Nor Laegeforen 2000; 9: 1000–1003.
Rose V, Izukawa T, Moes AF. Syndromes of asplenia and polysplenia. A review of cardiac and non-cardiac malformations in 60 cases with special reference to diagnosis and prognosis. Br Heart J 1975; 37: 840–852.
Wolfe MW, Vaeck JL, Kinard RE, Bailey CG. Prolonged and functional survival with the asplenia syndrome. Am J Med 1986; 81: 1089–1091.
Lin AE, Ticho BS, Houde K, Westgate MN, Holmes LB. Heterotaxy: associated conditions and hospital-based prevalence in newborns. Genet Med 2000; 2: 157–172.
Gibbs JL, Monro JL, Cunningham D, Rickards A. Survival after surgery or therapeutic catheterisation for congenital heart disease in children in the United Kingdom: analysis of the central cardiac audit database for 2000–1. BMJ 2004; 328: 611–615.
Al-Hay AA, MacNeill SJ, Yacoub M, Shore DF, Shinebourne EA. Complete atrioventricular septal defect, Down's syndrome, and surgical outcome: risk factors. Ann Thorac Surg 2003; 75: 412–421.
Moller JH, Powel CB, Joransen JA, Borbas C. The pediatric care consortium – revisited. Jt Comm J Qual Improv 1994; 20: 661–668.
Jenkins KJ, Gauvreau K. Center-specific differences in mortality: preliminary analyses using the risk adjustment in congenital heart surgery (RACHS-1) method. J Thorac Cardiovasc Surg 2001; 124: 97–104.
Halnon NJ, Wetzel GT. Implications of improving survival in the management of life-threatening congenital heart disease: new challenges in pediatric cardiology. Curr Opin Cardiol 2002; 17: 271–273.
Robinson WM, Newburger JW. Ethical issues concerning cardiac surgery in patients with syndromic abnormalities. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003; 6: 147–151.